Crohn’S Disease Equipment
-
by Abivaxbased in FRANCE
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in the completed Phase 2a and Phase 2b induction studies as well as in ongoing long-term maintenance studies in patients with moderate-to-severe ulcerative colitis (UC).Due to the clinical similarities of Crohn’s disease ...
-
Manufactured by Galapagos NVbased in BELGIUM
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs ...
-
Manufactured by MEDICA S.P.A.based in ITALY
Leukocyte Adsorber LA25: cartridge for selective leukocyte adsorption in the treatment of autoimmune diseases such as Crohn's disease and drug-unresponsiveulcerative rectocolitis. The cartridge uses a proprietary adsorption technology based on MediSulfone®. ...
-
Manufactured by NANOLEK LLCbased in RUSSIA
Anti-tumor necrosis factor-alpha monoclonalantibody. Effective in rheumathoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, ankylosing ...
-
Manufactured by Exeliom Biosciencesbased in FRANCE
diseases, starting with Crohn's Disease as a first ...
-
Manufactured by Setpoint Medical Corporationbased in USA
The SetPoint Medical bioelectronic medicine platform delivers targeted electrical pulses to trigger the intrinsic inflammatory reflex. This pathway shows promise as an alternative, efficient treatment option for rheumatoid arthritis (RA), Crohn’s disease, and other chronic autoimmune diseases – that may reduce risk, lower ...
-
Manufactured by 3B Scientific GmbHbased in GERMANY
This model shows the usual benign and malignant changes in the colon and rectum. These include diverticula, polyps, hemorrhoids, fistulae, fissures, chronic inflammatory diseases (Crohn’s disease and ulcerative colitis), as well as intestinal cancer in various ...
-
by Verb Bioticsbased in USA
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. Discover the ...
-
Manufactured by Ferring Pharmaceuticalsbased in SWITZERLAND
PENTASA® (mesalazine) is Ferring’s product used for the treatment and long-term management of inflammatory bowel diseases (IBD) (Ulcerative colitis and Crohn’s ...
-
Manufactured by Enteromebased in FRANCE
Sibofimloc is a first-in-class, orally administered small molecule that is specifically designed to reduce the inflammatory cascade underlying Crohn’s disease and remain gut-restricted, to minimize absorption into the bloodstream. ...
-
Manufactured by Lumen Bioscience, Inc.based in USA
Inflammatory bowel disease (IBD) is a systemic autoimmune disease, but it has an obvious nexus with the gastrointestinal tract. The two main sub-varieties—Crohn’s disease and ulcerative colitis—have many available treatments on the market today, but it remains a major unmet medical need: current treatments are ...
-
Manufactured by Exeliom Biosciencesbased in FRANCE
Faecalibacterium prausnitzii (F. prau), a key bacterium to treat Crohn’s Disease Meet Faecalibacterium prausnitzii (F. prau) WHAT IS F. prau? F. prau, is a dominant member of the healthy gut microbiome. It accounts for 5% to 15% of the total fecal microbiome in healthy adults, which is simply colossal. F. prau is the most extreme ...
-
Manufactured by Finch Therapeutics Group, Inc.based in USA
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes ...
-
Manufactured by JD Bioscience Inc. (JDB)based in SOUTH KOREA
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory cytokines, such as IL-6 and TNF, produced by activated immune cells are suggested to drive the perpetuation of inflammation and tissue ...
-
Manufactured by Quay Pharmabased in UNITED KINGDOM
the stomach can be coated to pass through the stomach intact. For the treatment of local diseases such as ulcerative colitis, Crohn’s disease or irritable bowel syndrome, drugs can be released at the local area of the disease. These enhanced coatings can also be used to mask unpleasant tastes and odours. ...
-
Manufactured by BIOHIT Healthcare Ltdbased in UNITED KINGDOM
SmarTest® faecal calprotectin home test is a simple-to-use inflammatory bowel disease stool test that enables individuals with Crohn’s disease or Ulcerative colitis to monitor their disease activity at home. Patients can use the quantitative calprotectin test at home, or indeed anywhere, with minimum test preparation or ...
-
Manufactured by Infomed SAbased in SWITZERLAND
Hemoperfusion can be used to directly remove specific substances from the blood by adsorption, a technique which fixes substances on a surface. It is of particular interest for leukocytes which are too big to be filtrated without major loss of red ...
-
Manufactured by RedHill Biopharma Ltd.based in ISRAEL
RHB-104 is a potentially groundbreaking, proprietary investigational drug in oral capsule formulation, with potent intracellular, antimycobacterial and anti-inflammatory ...
-
Manufactured by F Care Systems NVbased in BELGIUM
The Fistura® procedure uses radio frequency thermocoagulation to treat anal fistulas utilising the emission of electromagnetic waves at a very high frequency (4MHz), similar to the principle of a microwave. This minimally invasive technique seals the fistula tract without having to open the anal sphincter and is performed in a day-case or the outpatient setting, with minimal discomfort for ...
-
Manufactured by Pathnosticsbased in USA
This test identifies genetic abnormalities in patients with Barrett’s esophagus and provides an indication of progression requiring additional procedures and targeted management. Utilizing cytology, immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH) testing on brushings from patients with Barrett’s esophagus, patient chromosomal alterations can be distinguished ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you